Transforming Growth Factor-<i>β</i>1 as a Common Target Molecule for Development of Cardiovascular Diseases, Renal Insufficiency and Metabolic Syndrome

<table>Cardiorenal immunohistochemistry of TGF-<i>β</i>1. TGF-<i>β</i>1-stained spots are observed in the myocardium (upper panels) and coronary artery (middle panels) in Ang II-infused wild-type mice (upper and middle panels).  Macroscopic renal injury and TGF-<i>β</i>1-stained renal glomerulus are found in Ang II-infused mice, especially eNOS<sup>-/-</sup> mice (lower panels).  Pitavastatin treatment attenuates cardiorenal TGF-<i>β</i>1 expression in Ang II-infused mice.  Modified from the article by Yagi et al. [<a href="/journals/crp/2011/175381/#B38">37</a>].</table>

Cardiology Research and Practice

fig2

Figure 2

Figure 2: Transforming Growth Factor-<i>β</i>1 as a Common Target Molecule for Development of Cardiovascular Diseases, Renal Insufficiency and Metabolic Syndrome 

Figure 2 | Transforming Growth Factor-β1 as a Common Target Molecule for Development of Cardiovascular Diseases, Renal Insufficiency and Metabolic Syndrome 